Georgia may have secured its running back of the future on Monday afternoon. The Bulldogs have landed a commitment from 5-star running back Kemon Spell, beating out a host of top programs including ...
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results